Literature DB >> 6800832

Comparison of the anti-inflammatory effects of dexamethasone, indomethacin and BW755C on carrageenin-induced pleurisy in rats.

K Miyasaka, T Mikami.   

Abstract

In rat carrageenin pleurisy, dexamethasone (0.25 mg/kg p.o.) inhibited exudate accumulation in the pleural cavity throughout the period of testing while the non-steroidal anti-inflammatory drugs indomethacin (10 mg/kg p.o.) and BW755C (100 mg/kg p.o.) inhibited it for 6 and 9 h respectively after the intrapleural injection of carrageenin but not thereafter. These observations were confirmed by the finding that, of the treatments 6 h after carrageenin, only that with dexamethasone reduced exudate volume at 15 h after carrageenin. The anti-exudative action of dexamethasone at 15 h after carrageenin may be at least in part mediated by endogenous substance(s) formed through gene expression, because it was prevented by actinomycin D. Dexamethasone and BW755C markedly inhibited cell accumulation in the pleural exudate throughout the period tested, while indomethacin inhibited it significantly between 9-24 h after carrageenin.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6800832     DOI: 10.1016/0014-2999(82)90123-6

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  10 in total

1.  Induction of neutrophil infiltration by rat chemotactic cytokine (CINC) and its inhibition by dexamethasone in rats.

Authors:  N Hirasawa; M Watanabe; S Mue; K Watanabe; S Tsurufuji; K Ohuchi
Journal:  Inflammation       Date:  1992-04       Impact factor: 4.092

2.  Inhibition of the release of a neutrophil chemotactic factor from macrophages partially explains the anti-inflammatory action of glucocorticoids.

Authors:  F Q Cunha; A T Cacini; S H Ferreira
Journal:  Agents Actions       Date:  1986-01

3.  Pharmacological investigation of acute cellular accumulation in immunological air pouch inflammation.

Authors:  P Hambleton; P Miller
Journal:  Agents Actions       Date:  1989-08

4.  Comparative effects of carprofen, benoxaprofen and indomethacin on the development and decay phases of a carrageenan pleurisy in the rat.

Authors:  D Bradshaw; P H Franz; S J Greenham
Journal:  Agents Actions       Date:  1984-06

5.  Anti-inflammatory pharmacology and mechanism of the orally active capsaicin analogs, NE-19550 and NE-28345.

Authors:  L M Brand; K L Skare; M E Loomans; H H Reller; R J Schwen; D A Lade; R L Bohne; C S Maddin; D P Moorehead; R Fanelli
Journal:  Agents Actions       Date:  1990-11

6.  Suppression of inflammatory responses to 12-O-tetradecanoyl-phorbol-13-acetate and carrageenin by YM-26734, a selective inhibitor of extracellular group II phospholipase A2.

Authors:  A Miyake; H Yamamoto; E Kubota; K Hamaguchi; A Kouda; K Honda; H Kawashima
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

7.  Pharmacological modification of 12-0-tetradecanoylphorbol-13-acetate induced inflammation and epidermal cell proliferation in mouse skin.

Authors:  R J Griffiths; B E Wood; S Li; A Blackham
Journal:  Agents Actions       Date:  1988-12

8.  New approaches to clarify antinociceptive and anti-inflammatory effects of the ethanol extract from Vernonia condensata leaves.

Authors:  Jucélia Barbosa da Silva; Vanessa dos Santos Temponi; Felipe Valente Fernandes; Geórgia de Assis Dias Alves; Dalyara Mendonça de Matos; Carolina Miranda Gasparetto; Antônia Ribeiro; José de Jesus R G de Pinho; Maria Silvana Alves; Orlando Vieira de Sousa
Journal:  Int J Mol Sci       Date:  2011-12-07       Impact factor: 5.923

9.  Co-Administered Low Doses Of Ibuprofen And Dexamethasone Produce Synergistic Antinociceptive Effects On Neuropathic Mechanical Allodynia In Rats.

Authors:  Min K Park; Song H Kang; Jo Y Son; Min K Lee; Jin S Ju; Yong C Bae; Dong K Ahn
Journal:  J Pain Res       Date:  2019-10-30       Impact factor: 3.133

10.  Involvement of prostaglandins in inflammation induced by latex of Calotropis procera.

Authors:  Vijay L Kumar; Yatin M Shivkar
Journal:  Mediators Inflamm       Date:  2004-06       Impact factor: 4.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.